Lexeo Therapeutics LXEO Cash Flow Statement (2022-2026)

NASDAQ LXEO
$3.42 +0.28 (+8.92%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Lexeo Therapeutics Quarterly Cash Flow Statement

Periods 16 quarters
Latest Jun 2026

Lexeo Therapeutics reported cash from operations of -$17.60M and free cash flow of -$17.60M for the quarter ended Jun 2026, up 35.4% year over year. This cash flow statement covers 16 quarters of results from Sep 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -17.05M-14.58M-18.66M-13.44M-20.11M-14.19M-21.68M-21.24M-29.49M-25.92M-32.66M-26.10M-20.28M-20.92M-20.20M-25.87M
Depreciation and Depletion 0.05M0.09M0.07M0.08M0.08M0.08M0.09M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M
Share-based Compensation 0.43M0.52M0.40M0.97M0.88M0.80M2.33M2.85M3.79M3.51M3.70M3.07M2.65M2.71M2.75M5.69M
Cash from Operations -16.63M-18.37M-13.19M-13.95M-13.98M-14.87M-20.15M-17.81M-28.33M-21.72M-27.22M-29.55M-20.08M-21.14M-17.60M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization 0.05M0.06M0.06M0.06M0.08M0.08M0.07M0.08M0.08M0.07M0.06M0.06M0.07M0.07M0.07M0.07M
Change in Working Capital
Change in Account Payables -1.22M1.04M-1.91M0.29M0.39M0.64M1.06M2.72M-2.04M5.14M8.36M-15.27M0.20M-1.60M0.83M
Change in Accured Expenses -0.91M-1.79M1.20M4.80M-2.12M3.88M-3.87M5.27M-1.92M2.31M-7.14M1.00M-0.62M-1.09M0.69M
Other Working Capital Changes 0.83M-0.52M-0.09M-0.48M-0.32M-0.32M-0.34M-0.31M2.66M0.36M2.20M-3.67M3.11M1.12M-1.93M
Investing Activities
Capital Expenditures 0.03M0.01M0.04M0.02M0.04M0.18M0.21M0.08M0.29M0.04M0.01M
Change in Intangibles 0.08M0.01M0.01M-0.01M
Cash from Investing Activities -0.11M-0.05M-0.07M-0.19M-0.22M-0.08M-93.58M15.60M-39.17M35.01M-101.69M27.46M14.26M
Financing Activities
Other financing activities 0.07M
Debt Issuance and Repayment
Long-Term Debt Repayments 0.04M0.11M0.11M0.10M0.11M0.10M0.11M0.07M0.11M0.12M0.16M0.12M0.08M0.17M0.12M0.14M
Change in Capital Stock
Net Preferred Shares Issued and Repurchased -0.00M
Net Equity Issued and Repurchased 0.03M0.01M0.01M0.03M100.20M88.75M6.25M0.17M-0.17M0.27M79.73M2.45M22.55M
Misc.
Cash from Financing Activities -0.08M-0.10M-0.09M3.91M100.07M88.65M0.29M-0.07M-0.10M0.01M72.96M0.05M143.77M2.45M24.40M
Change in Cash -16.81M-18.47M-13.32M-10.09M86.02M73.59M-20.08M-17.96M-122.01M-6.11M6.57M5.52M22.00M8.77M21.07M
Free Cash Flow -16.65M-18.39M-13.23M-13.97M-14.02M-15.05M-20.36M-17.89M-28.33M-21.72M-27.22M-29.84M-20.08M-21.18M-17.60M
Net Cash Flow -16.81M-18.47M-13.29M-10.09M86.02M73.59M-20.08M-17.96M-122.01M-6.11M6.57M5.52M22.00M8.77M21.07M

Lexeo Therapeutics Cash Flow Statement API

Pull Lexeo Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LXEO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY